Filana Therapeutics, Inc. (FLNA) — Financial Flexibility Index
Latest as of March 2026:
-0.22x
Filana Therapeutics, Inc. (FLNA) has a Financial Flexibility Index of -0.22x as of March 2026. Free cash flow of $-8.88 Million (operating CF $-8.88 Million minus capex $0.00) represents 0% of total liabilities ($40.23 Million).
Financial Flexibility Index
-0.22x
Free Cash Flow / Total Liabilities
Free Cash Flow
$-8.88 Million
Operating CF − Capex
Total Liabilities
$40.23 Million
USD
Capital Expenditures
$0.00
USD
Filana Therapeutics, Inc. Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Filana Therapeutics, Inc. across 4 annual periods. See FLNA net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Filana Therapeutics, Inc. (2022–2025)
Year-by-year free cash flow to debt coverage for Filana Therapeutics, Inc.. For the full company profile including market capitalisation, see FLNA stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.72x | $-31.67 Million | $-32.25 Million | $43.95 Million | ▲ +92.7% |
| 2024 | -9.88x | $-116.83 Million | $-116.93 Million | $11.83 Million | ▼ -71.8% |
| 2023 | -5.75x | $-81.61 Million | $-82.03 Million | $14.20 Million | ▲ +43.9% |
| 2022 | -10.25x | $-74.80 Million | $-77.51 Million | $7.29 Million | — |
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities